Тёмный

Clinical Trial: Darzalex (daratumamab) with Revlimid/Velcade/Dex for Newly Diagnosed Myeloma 

HealthTree Foundation for Multiple Myeloma
Подписаться 6 тыс.
Просмотров 3,1 тыс.
50% 1

Peter Voorhees, MD of the Levine Cancer Institute shares a clinical trial for newly diagnosed myeloma patients using Darzalex (daratumumab), Revlimid, Velcade and dexamethasone before transplant, then adding dara into consolidation and maintenance post transplant. For more clinical trials, go to www.healthtree...

Опубликовано:

 

8 сен 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии : 3   
@JetLag52
@JetLag52 4 года назад
Just celebrated the first anniversary under RVD + Daratumumab therapy. 4 cycles followed by mobilisation & transplant; After 3 months of recovery I went through 2 more cycles and now I started a 2 years long therapy of montly subcutaneous Daratumumab. Results seem to be hopeful and I admit I had almost no adverse events along this one-year journey. I feel good !
@jennyahlstrom23
@jennyahlstrom23 4 года назад
Good to hear Vincent!
@vickyrodden5273
@vickyrodden5273 3 года назад
Hello, Dr. Voorhees How long before we see improvement for Myeloma when taking Darzalex? This is my husbands third week. Thank you
Далее
All About Darzalex (daratumumab)
14:28
Просмотров 8 тыс.
🎙А не СПЕТЬ ли мне ПЕСНЮ?🍂
3:04:50
Нарвался на сотрудника ФСБ⚡️
01:00
Understanding Clinical Trials
6:59
Просмотров 367 тыс.
Emotional Intelligence: From Theory to Everyday Practice
1:02:29
All About Revlimid (lenalidomide)
17:13
Просмотров 13 тыс.
Understanding pain in early multiple myeloma
22:25
Просмотров 11 тыс.
What are Trispecific antibodies?
4:37
Просмотров 653